<DOC>
	<DOCNO>NCT00849966</DOCNO>
	<brief_summary>The investigator ' study involve administration either placebo celecoxib child age 2 18 year age undergoing tonsillectomy assess pain relief , impact quality life side effect profile .</brief_summary>
	<brief_title>Celecoxib Pediatric Adenotonsillectomy</brief_title>
	<detailed_description>The study consist two arm , one placebo celecoxib . To establish baseline data day surgery parent require complete validated parent report quality life inventory , multi-dimension fatigue scale pediatric pain questionnaire precede week . Children/adolescents age 8 18 year age require complete child self-report module . Children undergo adenotonsillectomy receive either placebo celecoxib mouth one hour prior surgery . They receive preoperative acetaminophen . Premedication midazolam discretion attend anesthesiologist . The patient undergo standardize anesthetic protocol include postoperative management pain nausea vomiting . The patient , anesthesia , blood drawn screen occult liver kidney disease , determine CYP2C9 genotype reserve future gene chip micro array analysis . Patients study arm receive second dose celecoxib placebo mouth even surgery consecutively morning even 72 hour . For seven day surgery family record day pain score , document analgesic use side effect adverse event . The family contact phone evening first three postoperative day ensure understand completing require documentation . On seventh postoperative day parent child age 8 18 year age contact phone instruct complete two validated questionnaire concern quality life level fatigue complete day surgery . Parents child less eight year age responsible complete questionnaire base observation child . On 11th postoperative day family contact e-mail regular mail complete questionnaire ask extent contact healthcare system , bleed complication , recovery overall satisfaction care .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Children age 218 year Tonsillectomy , adenotonsillectomy No exclusion criterion Age &lt; 2yrs &gt; 18yrs old BMI &lt; 10th &gt; 95th percentile Serum creatinine ( Cr ) &gt; 2 X UNL ( upper normal limit ) Abnormal liver function ; namely alanine aminotransferase ( ALT ) &gt; 1.5 X UNL , alkaline phosphatase ( ALP ) &gt; 5X UNL , total bilirubin &gt; 2 X UNL History peptic ulcer disease . History bleed disorder History severe asthma ( require recent hospital admission oral corticosteroid therapy ) Allergy celecoxib , sulfonamide compound NSAIDs Patients receive CYP2C9 inhibitor fluconazole , amiodarone oxandrolone Patients receive CYP2C9 inducer rifampin phenobarbital Extremes body mass index ( BMI ) ( age relate below10th 90th percentile ) Parents participant , irrespective age , unable read understand instruction relay English French Participant and/or parent participant , irrespective age , suffer dementia , psychosis , significant developmental delay impairment would prohibit understanding give informed consent assent participation selfcare toxicity reporting</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Celebrex</keyword>
	<keyword>celecoxib</keyword>
	<keyword>Cyclooxygenase Inhibitors</keyword>
	<keyword>Anti-Inflammatory Agents Non-Steroidal</keyword>
	<keyword>Adverse drug event</keyword>
	<keyword>quality life</keyword>
	<keyword>Pain Postoperative</keyword>
	<keyword>Tonsillectomy</keyword>
	<keyword>Adenotonsillectomy</keyword>
	<keyword>Otologic Surgical Procedures</keyword>
</DOC>